YU240589A - Process for making transdermal therapy system with neopseudoefecrine as active component - Google Patents

Process for making transdermal therapy system with neopseudoefecrine as active component

Info

Publication number
YU240589A
YU240589A YU02405/89A YU240589A YU240589A YU 240589 A YU240589 A YU 240589A YU 02405/89 A YU02405/89 A YU 02405/89A YU 240589 A YU240589 A YU 240589A YU 240589 A YU240589 A YU 240589A
Authority
YU
Yugoslavia
Prior art keywords
neopseudoefecrine
active component
therapy system
transdermal therapy
weight
Prior art date
Application number
YU02405/89A
Other versions
YU47075B (en
Inventor
T Hille
Original Assignee
Lts Gmbh Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Gmbh Co Kg filed Critical Lts Gmbh Co Kg
Priority to SI8912405A priority Critical patent/SI8912405A/en
Publication of YU240589A publication Critical patent/YU240589A/en
Priority to HR930586A priority patent/HRP930586A2/en
Publication of YU47075B publication Critical patent/YU47075B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to a transdermal therapeutic system for applying an active substance to the skin and consisting of a backing layer impermeable to the active substance, a reservoir layer and, if appropriate, a detachable protective layer, the reservoir layer being adhesive and containing 10-90% by weight of polymer material, 0-30% by weight of softener and 0.1-20% by weight of a norpseudoephedrine.
YU240589A 1988-12-22 1989-12-19 PROCEDURE FOR DEVELOPING A TRANSDERMAL THERAPEUTIC SYSTEM WITH NOEPSEUDIEPHEDRINE AS AN ACTIVE INGREDIENT YU47075B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SI8912405A SI8912405A (en) 1988-12-22 1989-12-19 Process for production of transdermal therapeutical system comprising norpseudoephedrine as active component
HR930586A HRP930586A2 (en) 1988-12-22 1993-03-29 Process for the production of transdermal therapeutic em with norpseudoeffedrine as an active substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3843237A DE3843237A1 (en) 1988-12-22 1988-12-22 TRANSDERMAL THERAPEUTIC SYSTEM WITH AN ANTIADIPOSITUM AS AN ACTIVE INGREDIENT

Publications (2)

Publication Number Publication Date
YU240589A true YU240589A (en) 1991-04-30
YU47075B YU47075B (en) 1994-12-28

Family

ID=6369853

Family Applications (1)

Application Number Title Priority Date Filing Date
YU240589A YU47075B (en) 1988-12-22 1989-12-19 PROCEDURE FOR DEVELOPING A TRANSDERMAL THERAPEUTIC SYSTEM WITH NOEPSEUDIEPHEDRINE AS AN ACTIVE INGREDIENT

Country Status (23)

Country Link
EP (1) EP0374725B1 (en)
JP (1) JP2602108B2 (en)
KR (1) KR950015055B1 (en)
AT (1) ATE93147T1 (en)
AU (1) AU614208B2 (en)
CA (1) CA2006425C (en)
CS (1) CS275356B2 (en)
DD (1) DD290581A5 (en)
DE (2) DE3843237A1 (en)
DK (1) DK651089A (en)
ES (1) ES2045369T3 (en)
FI (1) FI95772C (en)
HU (1) HU203280B (en)
IE (1) IE63878B1 (en)
IL (1) IL92678A (en)
MY (1) MY105074A (en)
NO (1) NO178784C (en)
NZ (1) NZ231909A (en)
PH (1) PH25854A (en)
PL (1) PL163292B1 (en)
PT (1) PT92650B (en)
YU (1) YU47075B (en)
ZA (1) ZA899879B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3939376C1 (en) * 1989-11-29 1991-05-08 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De
DE4342893C2 (en) * 1993-12-16 1999-09-23 Lohmann Gmbh & Co Kg Reversible adhesive, residue-free removable pressure sensitive adhesive, process for its production and use as re-adhesive pressure sensitive adhesive articles
AU2727801A (en) * 1999-12-16 2001-06-25 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
US6602912B2 (en) 2000-06-30 2003-08-05 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
US6673363B2 (en) 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US6719997B2 (en) 2000-06-30 2004-04-13 Dermatrends, Inc. Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
KR100956865B1 (en) * 2009-08-10 2010-05-11 주식회사 라이트론 Slide pressure packing type linear lighting apparatus
US20190298661A1 (en) * 2016-10-31 2019-10-03 The Corporation Of Mercer University Transdermal Delivery of Phenethylamine Monoamine Releasers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
JPS57116011A (en) * 1981-01-08 1982-07-19 Nitto Electric Ind Co Ltd Pharmaceutical preparation
JPS60185713A (en) * 1984-03-05 1985-09-21 Nitto Electric Ind Co Ltd Percutaneous preparation and its production
EP0156080B2 (en) * 1984-03-05 1993-10-20 Nitto Denko Corporation Percutaneous absorption type adhesive pharmaceutical preparation
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
DE3629304A1 (en) * 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg TRANSDERMAL THERAPEUTIC SYSTEM, ITS USE AND METHOD FOR THE PRODUCTION THEREOF
DE3743945A1 (en) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg DEVICE FOR DELIVERING SUBSTANCES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE

Also Published As

Publication number Publication date
CS8907193A3 (en) 1992-02-19
CA2006425C (en) 1995-09-05
AU614208B2 (en) 1991-08-22
IL92678A (en) 1994-06-24
PT92650A (en) 1990-06-29
NO178784C (en) 1996-06-05
JP2602108B2 (en) 1997-04-23
FI95772B (en) 1995-12-15
ZA899879B (en) 1990-09-26
ES2045369T3 (en) 1994-01-16
CA2006425A1 (en) 1990-06-22
PH25854A (en) 1991-12-02
IE63878B1 (en) 1995-06-14
EP0374725A3 (en) 1990-12-19
KR950015055B1 (en) 1995-12-21
JPH03123728A (en) 1991-05-27
DE3843237C2 (en) 1991-04-11
DE58905320D1 (en) 1993-09-23
EP0374725A2 (en) 1990-06-27
PT92650B (en) 1995-09-12
ATE93147T1 (en) 1993-09-15
HUT53517A (en) 1990-11-28
NZ231909A (en) 1991-06-25
IL92678A0 (en) 1990-09-17
NO178784B (en) 1996-02-26
EP0374725B1 (en) 1993-08-18
FI896097A0 (en) 1989-12-19
DK651089D0 (en) 1989-12-20
IE894077L (en) 1990-06-22
DE3843237A1 (en) 1990-07-05
DK651089A (en) 1990-06-23
HU896721D0 (en) 1990-02-28
DD290581A5 (en) 1991-06-06
PL163292B1 (en) 1994-03-31
MY105074A (en) 1994-07-30
KR900009063A (en) 1990-07-02
CS275356B2 (en) 1992-02-19
AU4684389A (en) 1990-06-28
FI95772C (en) 1996-03-25
YU47075B (en) 1994-12-28
HU203280B (en) 1991-07-29
NO895173L (en) 1990-06-25
NO895173D0 (en) 1989-12-21

Similar Documents

Publication Publication Date Title
HUT55643A (en) Process for producing transdermal therapy system containing buprenorfin as agent
YU240789A (en) Process for making transdermal therapy system with phisostigmine as active component
HU896714D0 (en) Process for producing of medical device containing fisostigmine as agent being absorbed by skin
YU240589A (en) Process for making transdermal therapy system with neopseudoefecrine as active component